Trials / Completed
CompletedNCT00110435
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
A Multicenter, Randomized, Double-blind, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,229 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this 10-week study is to compare the reduction in cholesterol following treatment with two different marketed drugs, in patients with type 2 diabetes mellitus and hypercholesterolemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653A, ezetimibe (+) simvastatin | |
| DRUG | Duration of Treatment: 4 wk placebo run in then 6 wk active | |
| DRUG | Comparator: atorvastatin |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-05-10
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00110435. Inclusion in this directory is not an endorsement.